AccelBio is proud to share the approval of two projects under the FCT Exploratory Projects call:
- Deciphering MicroRNA Mechanisms of Action via High-Dimensional Multiparametric Cell Painting Assay
A cutting-edge Cell Painting approach to map miRNA mechanisms by matching phenotypic signatures to profiles generated with FDA-approved compounds.
- Exploiting Novel Host-Directed Antimicrobials for Combating Infections by Staphylococcus aureus
A newly established approach to identify host-directed candidates that may be used alone or in combination with classical antibiotics.
These projects reinforce our commitment to enabling high-impact translational science and expanding innovative pipelines.
